These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7751411)

  • 21. In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances.
    Gardiner SJ; Drennan PG; Begg R; Zhang M; Green JK; Isenman HL; Everts RJ; Chambers ST; Begg EJ
    PLoS One; 2018; 13(7):e0199370. PubMed ID: 30001392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ciprofloxacin in the elderly: increased oral bioavailability and reduced renal clearance.
    Ljungberg B; Nilsson-Ehle I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):515-20. PubMed ID: 2504591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of cephradine administered intravenously and orally to young and elderly subjects.
    Schwinghammer TL; Norden CW; Gill E
    J Clin Pharmacol; 1990 Oct; 30(10):893-9. PubMed ID: 2229449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S; van Berlo I; Ten Oever J; Jansman F; Ter Heine R
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers.
    Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE
    J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral absorption of flucloxacillin in infants and young children.
    Bergdahl S; Eriksson M; Finkel Y; Lännergren K
    Acta Pharmacol Toxicol (Copenh); 1986 Apr; 58(4):255-8. PubMed ID: 3716820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic disposition of flucloxacillin in patients with impaired kidney function.
    Thijssen HH; Wolters J
    Eur J Clin Pharmacol; 1982; 22(5):429-34. PubMed ID: 7117355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Eur J Clin Pharmacol; 1980 May; 17(5):385-91. PubMed ID: 7418717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extravascular penetration of highly protein-bound flucloxacillin.
    Bergan T; Engeset A; Olszewski W; Ostby N; Solberg R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):729-32. PubMed ID: 3800349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of high-performance liquid chromatographic analysis for isoxazolyl penicillins using factorial design.
    Hung CT; Lim JK; Zoest AR; Lam FC
    J Chromatogr; 1988 Mar; 425(2):331-41. PubMed ID: 3372647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of amoxicillin and flucloxacillin following the simultaneous intravenous administration of 4 g and 1 g, respectively.
    Adam D; Koeppe P; Heilmann HD
    Infection; 1983; 11(3):150-4. PubMed ID: 6885174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G
    Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.